New network sets the stage for breakthroughs in advanced therapy regulation

A new initiative aims to revolutionise the regulatory landscape for advanced therapies in the UK, ensuring patients can quickly access transformative treatments. A collaboration between the Cell and Gene Therapy Catapult (CGT Catapult) and the Birmingham Health Partners Centre for Regulatory Science and Innovation (CRSI) seeks to create a dynamic framework that supports the swift development, testing, and rollout of cutting-edge therapies. With funding from Innovate UK and support from the MHRA, this network brings together regulators, researchers, and industry leaders to drive innovation while maintaining patient safety.

Advanced therapies, such as gene and cell treatments, offer unprecedented potential to change the way diseases are treated. However, their complexity demands a regulatory system that adapts to the unique challenges these therapies present. The new network aims to collaborate with UK regulators, particularly the MHRA, to develop effective regulatory strategies tailored to these next-generation treatments. Its focus is on ensuring that the regulatory environment encourages innovation while safeguarding public health.

Through this collaborative effort, the network will create a regulatory ecosystem that positions the UK as a global leader in advanced therapy development. By identifying key regulatory solutions and sharing them with stakeholders across the healthcare and research sectors, the initiative will work to streamline the path from development to patient access, ensuring timely, safe, and effective treatments.

Matthew Durdy, Chief Executive of CGT Catapult, emphasised the importance of this initiative: “Advanced therapies present both a significant opportunity for patients and a chance for the UK to lead globally in this field. This network will play a key role in making that happen.”

Melanie Calvert, Deputy Director of CRSI, underscored the importance of involving the patient voice in shaping regulatory decisions. “As the number of advanced therapies grows, it's crucial that regulatory frameworks evolve to meet the needs of patients. Our work will ensure these therapies are developed with patient-centric insights, leading to quicker access to life-changing treatments.”

This network is one of seven new Centres of Excellence established by Innovate UK to enhance the development and approval of medical innovations across the country.

More information online